Compound information
- Natural Products
- ZC537567
- Molecular Formula
- C17H22N2O4S
- Molecular Weight
- 350.130028184 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(4-ethynylphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C17H22N2O4S/c1-5-14-6-8-15(9-7-14)24(21,22)19-12-10-18(11-13-19)16(20)23-17(2,3)4/h1,6-9H,10-13H2,2-4H3
- InChI Key
- LSSTVRBCIGMSMU-UHFFFAOYSA-N
- SMILES
- C#Cc1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000095740383
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 24 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.643 |
LogS | -4.093 | LogD | 3.437 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.05 | Pgp substrate | 0.012 |
HIA | 0.965 | F20 % | 0.991 |
F30 % | 0.945 | Caco-2 | -4.386 |
MDCK | -4.959 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.823 | PPB | 93.204 |
VD | 2.214 | Fu | 0.821 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.022 | CYP1A2 substrate | 0.402 |
CYP2A6 substrate | 0.601 | CYP2B6 substrate | 0.647 |
CYP2C19 inhibitor | 0.739 | CYP2C19 substrate | 0.785 |
CYP2C8 substrate | 0.608 | CYP2C9 inhibitor | 0.641 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.01 |
CYP2D6 substrate | 0.812 | CYP2E1 substrate | 0.883 |
CYP3A4 inhibitor | 0.071 | CYP3A4 substrate | 0.996 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.418 | CL | 7.385 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.932 | Hepatotoxicity | 1.0 |
Mutagenicity | 0.52 | Rat Oral Acute Toxicity | 0.303 |
FDAMDD | 0.376 | Skin Sensitization | 0.083 |
Carcinogenicity | 0.97 | Eye Corrosion | 0.027 |
Eye Irritation | 0.231 | Respiratory Toxicity | 0.496 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.756 | IGC50 | 4.133 |
LC50FM | 2.228 | LC50DM | 4.37 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.218 | NR-AR-LBD | 0.303 |
NR-AhR | 0.029 | NR-Aromatase | 0.687 |
NR-ER | 0.244 | NR-ER-LBD | 0.448 |
NR-PPAR-gamma | 0.131 | SR-ARE | 0.804 |
SR-ATAD5 | 0.386 | SR-HSE | 0.085 |
SR-MMP | 0.028 | SR-p53 | 0.026 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.